檢索結果 - Karwatowska‐Prokopczuk, Ewa
- Showing 1 - 6 results of 6
-
1
-
2
Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study 由 Foss-Freitas, Maria C., Akinci, Baris, Neidert, Adam, Bartlett, Victoria J., Hurh, Eunju, Karwatowska-Prokopczuk, Ewa, Oral, Elif A.
出版 2021Text -
3
Treatment with Volanesorsen, a 2′-O-Methoxyethyl-Modified Antisense Oligonucleotide Targeting APOC3 mRNA, Does Not Affect the QTc Interval in Healthy Volunteers 由 Watts, Lynnetta M., Karwatowska-Prokopczuk, Ewa, Hurh, Eunju, Alexander, Veronica J., Balogh, Kristin, O'Dea, Louis, Geary, Richard S., Tsimikas, Sotirios
出版 2020Text -
4
Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN‐TIMI... 由 Gutierrez, Jorge A., Karwatowska‐Prokopczuk, Ewa, Murphy, Sabina A., Belardinelli, Luiz, Farzaneh‐Far, Ramin, Walker, Gennyne, Morrow, David A., Scirica, Benjamin M.
出版 2015Text -
5
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and... 由 Gaudet, Daniel, Karwatowska-Prokopczuk, Ewa, Baum, Seth J, Hurh, Eunju, Kingsbury, Joyce, Bartlett, Victoria J, Figueroa, Amparo L, Piscitelli, Philip, Singleton, Walter, Witztum, Joseph L, Geary, Richard S, Tsimikas, Sotirios, O'Dea, Louis St. L
出版 2020Text -
6
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk 由 Tardif, Jean-Claude, Karwatowska-Prokopczuk, Ewa, Amour, Eric St, Ballantyne, Christie M, Shapiro, Michael D, Moriarty, Patrick M, Baum, Seth J, Hurh, Eunju, Bartlett, Victoria J, Kingsbury, Joyce, Figueroa, Amparo L, Alexander, Veronica J, Tami, Joseph, Witztum, Joseph L, Geary, Richard S, O’Dea, Louis St L, Tsimikas, Sotirios, Gaudet, Daniel
出版 2022Text